Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE To compare associations of current and past self-reported bone-specific physical activity, and current accelerometer-determined physical activity (PA), with bone structure (bone mineral density [BMD] and microarchitecture) in postmenopausal women with osteopenia or osteoporosis. 31720706 2020
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE In addition, reduced endocortical erosion depth with no change of wall thickness may contribute to increased bone strength by reducing the bone loss and fragility associated with deep resorption cavities and may likely contribute to the greater BMD gain with denosumab than with other antiresorptive agents.© 2018 The Authors. 30601581 2019
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 AlteredExpression disease BEFREE The objectives of this study are to assess the correlation between BMD and serum lipid levels, to determine independent variables associated with osteoporosis and osteopenia in men and postmenopausal women with type 2 diabetes (T2D). 30235494 2019
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE We divided our population into 5 groups with different phenotypes characterizing the severity of the disease and/or the severity of bone involvement: 1 - Normal BMD and body mass index (BMI): recovery from AN; 2 - Osteopenia (-2<Z-score<-1) and BMI>17kg/m<sup>2</sup>; 3 - Osteopenia and BMI≤17kg/m<sup>2</sup>; 4 - Osteoporosis (Z-score≤-2) and BMI>17kg/m<sup>2</sup>; 5 - Osteoporosis and BMI≤17kg/m<sup>2</sup>. 29653285 2019
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE We investigated investigate the association between BMD and mortality, and to examine whether the rate of bone loss can predict future mortality in an elderly population. 30660675 2019
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE The combination significantly improved the lumbar spine and hip BMD and reduced FRAX scores, suggesting that ZOL combined with MTX reduces bone loss and risk of hip fracture in RA patients with secondary osteoporosis. 31823822 2019
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE Mean BMD was lower in men compared with women aged 50-60 years, but accelerated bone loss in women during this early post-menopausal period resulted in lower BMD values for women beyond age 60. 30433815 2019
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 AlteredExpression disease BEFREE The levels of OC were significantly different in women with osteopenia and osteoporosis (ANOVA, p < .0001) compared to women with normal BMD. 30537473 2019
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 GeneticVariation disease BEFREE Faecal microbiota profiles were determined from 181 individuals with osteopenia (n = 61) or osteoporosis (n = 60), and an age- and gender-matched group with normal BMD (n = 60). 31378815 2019
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE A total of 56/84 SSc patients (66%) as well as 78/98 RA patients (80%) showed bone loss at DXA and BMD was found to be significantly lower than in the CNT (P < 0.001). 29788459 2018
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE We secondarily compared microRNA-21 expression between participants with normal and low bone mineral density (BMD: osteopenia and osteoporosis). 30232913 2018
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE The rate of longitudinal bone lossBMD) is a risk factor for fracture. 29931598 2018
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE The DG presented a higher frequency of abnormal BMD (osteopenia in 45 (53%), and osteoporosis in 14 (19%)) and comorbidities than the CG (p < 0.005). 29632617 2018
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE We previously reported that 12months of resistance training (RT, 2×/wk, N=19) or jump training (JUMP, 3×/wk, N=19) increased whole body and lumbar spine BMD and increased serum bone formation markers relative to resorption in physically active (≥4h/wk) men (mean age: 44±2y; median: 44y) with osteopenia of the hip or spine. 27744012 2017
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE The resulting 10-year fracture probabilities were assessed against the US and the UK treatment guidance to determine the amount of premenopausal BMD and TBS loss that would result in a recommendation to initiate medical treatment to reduce fracture risk later in life that would not otherwise have been recommended in the absence of premenopausal bone loss. 29018923 2017
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE The aims of this study were to investigate on a population-level the association between lumbar BMD and SUA within the normal physiologic range and to determine whether SUA plays a protective role in bone loss in healthy postmenopausal Chinese women. 28527105 2017
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE The estimated BMD testing interval for 10 % of patients to develop osteoporosis was 9.6 years for those with normal BMD, 7.6 years for those with mild osteopenia, 4.7 years for those with moderate osteopenia, and 2.1 years for those with severe osteopenia. 27509834 2017
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE In multivariable analyses, osteopenia (OR = 4.75 95% CI 1.23-17.64) or osteoporosis (OR = 4.31, 95% CI 1.15-16.23) compared with normal BMD was significantly associated with fractures and higher T-scores at the hip were inversely associated with fractures (OR 0.73 (95% CI 0.57-0.92)). 27924381 2017
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 AlteredExpression disease BEFREE In women with osteopenia BMD L2-L4 YA (%) and BMD L2-L4 AM (%) were significantly higher in women with genotype AA, but BMD L2-L4 was significantly higher in women with genotype TT. 25980946 2015
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 GeneticVariation disease BEFREE Carriers of the CIITA rs3087456(G) allele had 1.8-3.4% higher BMD and displayed increased rate of bone loss between age 75 and 80 (FN p = 0.013; total hip p = 0.030; total body p = 3.8E(-5)). 23133532 2012
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE Patient BMD contrasts with radiographic osteopenia and histomorphometry without osteosclerosis. 21344539 2011
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE A haplotype comprising all the common alleles (frequency 9%) was associated with decreased bone loss at the hip (p < 0.05) and decreased incidence of osteoporotic fractures (p < 0.05) in DOPS and increased femoral neck BMD in AROS (p < 0.05). 21104233 2011
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE Although there is a significant genetic effect on peak BMD, until recently, no substantive studies on heritability of bone loss in human were available. 18810303 2009
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE The genetic deficit in BMD was already present before 35 yr of age and equaled bone loss during 8-30 yr after menopause. 18505373 2008
Entrez Id: 1756
Gene Symbol: DMD
DMD
0.100 Biomarker disease BEFREE BMD at the hip and lumbar spine significantly decreased through the passage to menopause, indicating no protection to bone loss. 17295608 2007